The National Cancer Control Programme (NCCP) Technology Review Committee was established in March 2011 and is responsible for reviewing proposals received from industry or expert groups in Ireland for funding of new cancer drugs, or expanded indications for existing cancer drugs or related predictive laboratory tests. The recommendations are based on the degree of clinical effectiveness, the acute and chronic toxicity and the cost effectiveness of the proposed technology.
Information on the NCCP Technology Review Committee is available by clicking on the attached document.
NCCP Technology Review Committee.pdf
NCCP Technology Review Committee Terms of Reference
Details of new drugs recommended for reimbursement by the NCCP Technology Review Committee to the HSE Drug Committee are available here.
Minutes of TRC Meetings:
2018 January - December
Meeting 1: 7th March 2018
Meeting 2: 29th May 2018
Meeting 3: 3rd September 2018
Meeting 4: 25th September 2018
Meeting 5: 16th October 2018
Meeting 6: 20th November 2018
2019 January to December
Meeting 1: 26th March 2019
Meeting 2: 3rd September 2019
Meeting 3: 4th November 2019
2020 January to December
Meeting 1: 24th February 2020
Meeting 2: 6th July 2020
Meeting 3: 22nd September 2020
Meeting 4: 16th November 2020
2021 January to December
Meeting 1: 1st February 2021
Meeting 2: 1st March 2021
Meeting 3: 29th March 2021
Meeting 4: 26th April 2021
Meeting 5: 27th September 2021
Meeting 6: 29th November 2021
2022 January to December
Meeting 1: 24th January 2022
Meeting 2: 21st February 2022
Meeting 3: 4th April 2022
Meeting 4: 30th May 2022
Meeting 5: 27th June 2022
Meeting 6: 29th August 2022
Meeting 7: 24th October 2022
Meeting 8: 28th November 2022
